Search hospitals > South Carolina > Greenville
Saint Francis Cancer Center
Claim this profileGreenville, South Carolina 29607
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Non-Small Cell Lung Cancer
186 reported clinical trials
10 medical researchers
Summary
Saint Francis Cancer Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Cancer Center is involved with conducting 186 clinical trials across 358 conditions. There are 10 research doctors associated with this hospital, such as Robert D. Siegel, Howland Crosswell, Jennifer Vogel, and David Griffin.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage I
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Robert D. SiegelSaint Francis Cancer Center6 years of reported clinical research
Expert in Lung Cancer
Expert in Breast Cancer
59 reported clinical trials
116 drugs studied
Howland CrosswellSaint Francis Cancer Center6 years of reported clinical research
Studies Hodgkin's Lymphoma
Studies Leukemia
17 reported clinical trials
46 drugs studied
Jennifer VogelSaint Francis Cancer Center3 years of reported clinical research
Studies Breast Cancer
Studies Prostate Cancer
8 reported clinical trials
33 drugs studied
David GriffinSaint Francis Cancer Center7 years of reported clinical research
Studies Uterine Cancer
Studies Ovarian Cancer
8 reported clinical trials
36 drugs studied
Clinical Trials running at Saint Francis Cancer Center
Lung Cancer
Cancer
Breast Cancer
Prostate Cancer
Melanoma
Multiple Myeloma
Testicular cancer
Small Cell Lung Cancer
Non-Small Cell Lung Cancer
Colorectal Cancer
Telisotuzumab Vedotin vs. Docetaxel
for Non-Small Cell Lung Cancer
This trial is testing a new drug called telisotuzumab vedotin to see if it can treat a specific type of lung cancer better than an existing drug. The study focuses on adults whose lung cancer has not responded to previous treatments. The new drug targets and kills cancer cells by attaching to a specific protein on their surface.
Recruiting2 awards Phase 312 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Francis Cancer Center?
Saint Francis Cancer Center is a medical facility located in Greenville, South Carolina. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Non-Small Cell Lung Cancer and other specialties. Saint Francis Cancer Center is involved with conducting 186 clinical trials across 358 conditions. There are 10 research doctors associated with this hospital, such as Robert D. Siegel, Howland Crosswell, Jennifer Vogel, and David Griffin.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.